Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1

National Institutes of Health (NIH)

Status and phase: Unknown; Phase 1

Conditions: Cocaine-Related Disorders

Treatments: Drug: GBR 12909

Study type: Interventional

Funder types: NIH

Identifiers

NCT00051896

NIDA-CPU-0002-1

Details and patient eligibility

About

The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.

Full description

This is a single dose with escalation, double-blind, placebo-controlled inpatient study in which 24 cocaine experienced volunteers that meet protocol eligibility criteria during a 30 day screen period will be randomized into three dose groups.

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must understand study procedures and provide written informed consent
• For additional inclusion criteria information, please contact study site for more information.

Exclusion criteria

• Please contact study site for more information.